Redcare appoints a CEO. Redcare Pharmacy stock is 1.16 percent below its Xetra close of EUR 74.80.
Published on 10/18/2026 at 17:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCEO appointment and dates
- Peter Schmid von Linstow became CEO on October 14, 2026.
- Redcare Pharmacy stock trades in weekend trading at Lang & Schwarz at EUR 73.93 at 5:45 p.m. CEST on October 18, 2026, 1.16 percent below the Xetra close of October 16, 2026.
- The next Xetra session is October 19, 2026.
Redcare Pharmacy N.V. appointed Peter Schmid von Linstow to its Managing Board and as chief executive officer effective October 14, 2026, according to an EQS News release. The company said the appointment followed consultation with its extraordinary general meeting of shareholders.
Redcare Pharmacy stock trades in weekend trading at Lang & Schwarz at EUR 73.93 at 5:45 p.m. CEST on October 18, 2026. That is 1.16 percent below the Xetra close of October 16, 2026, at EUR 74.80. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Redcare Pharmacy stock.
Redcare Pharmacy’s announcement said Schmid brings more than 20 years of international leadership experience at digital platforms and marketplaces, including Visable, Parship, eBay and AutoScout24. The company also stated that it generated EUR 2.9 billion in revenue in 2025 and serves more than 14 million active customers, according to the EQS release.
Market context: Market report SDAX.
The week in figures
The October 18 weekend-trading price was EUR 73.93 at Lang & Schwarz. The reference level was the Xetra close of October 16, 2026, at EUR 74.80, putting the weekend-trading price 1.16 percent lower.
Chronology of the week
On October 14, 2026, Redcare Pharmacy appointed Peter Schmid von Linstow as chief executive officer, effective immediately, according to the company’s EQS announcement.
Dates of the coming week
The next Xetra session is October 19, 2026. Redcare Pharmacy’s next scheduled interim statement, according to the company’s published calendar, is due on October 29, 2026.
